Friday, July 10, 2026

pharma · Asthma · Idiopathic pulmonary fibrosis (IPF)

Chiesi Farmaceutici S.p.A

NovaPharmaNews editorial coverage mentioning Chiesi Farmaceutici S.p.A — regulatory, clinical, and market analysis.

Via Paradigna, 131, Parma, Emilia-Romagna 43122, IT HQ
6,080 Employees
EMA registrant Type
Company details
Status
Public
HQ
Via Paradigna, 131, Parma, Emilia-Romagna 43122, IT
Employees
6,080
Programs
20
Drugs
38
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Chiesi Farmaceutici S.p.A — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Chiesi Farmaceutici S.p.A — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Chiesi Farmaceutici S.p.A yet.

Back to company overview →